FORTE BIOSCIENCES, INC. — Operating Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/37c9495f-8f4a-42cb-a9a5-5e28142ce538/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-70.7M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-134498 |
| FY 2024 | $-36.6M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-046749 |
| FY 2023 | $-32.5M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-032843 |
| FY 2022 | $-13.9M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-011355 |
| FY 2021 | $-21.5M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-012987 |
| FY 2020 | $-46.3M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-013249 |
| FY 2019 | $-4.1M | 2019-01-01 – 2019-12-31 | evidence 0001564590-21-013249 |
| FY 2018 | $-45.9M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004933 |
| FY 2017 | $-37.6M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-004933 |
| FY 2016 | $-31.7M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-004933 |
| FY 2015 | $-23.0M | 2015-01-01 – 2015-12-31 | evidence 0001564590-18-005132 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).